IP Library Granted Patent US 9,103,841
Granted Patent B2
US 9,103,841 · App. 14/238,555 · Granted Aug 11, 2015

Method for determining glucagon-like peptide-1, and kit for use in said method

Inventors: China Sakai (Minato-ku, JP); Shigeru Tashiro (Minato-ku, JP)
Assignee: LSI MEDIENCE CORPORATION
G01N33/74G01N2333/605
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,103,841
App. No.
14/238,555
Granted
Aug 11, 2015
Kind
B2
Abstract

Provided is a method of measuring the presence and/or the amount of glucagon-like peptide-1 (GLP-1) in a sample, which method is characterized by comprising the step of treating the sample in advance with an acidic solution, and a kit of measuring the presence and/or an amount of GLP-1 in a sample, the kit containing (a) the acidic solution, (b) an antibody specific to GLP-1, and (c) an instruction manual.

Claims (13)

1. A method of measuring the presence and/or an amount of glucagon-like peptide-1 (GLP-1) in a sample isolated from a subject, comprising treating said sample isolated from a subject with an acidic solution, neutralizing the acidic solution and then measuring the presence and/or an amount of GLP-1 in the sample, wherein the acidic solution has a pH of 2.5 or less.

2. The method according to claim 1 , wherein said acidic solution comprises at least one of glycine, hydrochloric acid, sulfuric acid, and phosphoric acid.

3. The method according to claim 1 , wherein said sample is blood.

4. The method according to claim 1 , wherein said method of measuring GLP-1 comprises an enzyme immunoassay or a competitive radioimmunoassay.

5. A kit of measuring the presence and/or an amount of GLP-1 in a sample, comprising:

(a) an acidic solution having a pH of 2.5 or less,

(b) an antibody specific to GLP-1,

(c) an instruction manual, and

(d) an alkali solution for neutralization of the acidic solution.

6. The method according to claim 2 , wherein said sample is blood.

7. The method according to claim 2 , wherein said method of measuring GLP-1 comprises an enzyme immunoassay or a competitive radioimmunoassay.

8. The method according to claim 3 , wherein said method of measuring GLP-1 comprises an enzyme immunoassay or a competitive radioimmunoassay.

9. The method according to claim 6 , wherein said method of measuring GLP-1 comprises an enzyme immunoassay or a competitive radioimmunoassay.

Assignments (2)
CHANGE OF NAME Recorded Mar 17, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 035216/0537 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2014
From: SAKAI, CHINA; TASHIRO, SHIGERU
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 032203/0859 →
Priority Claims (1)
JP 2011-183791 · Aug 25, 2011 · national
Continuity (1)
Related Publication 20140199711A1 · Jul 17, 2014